Journal article icon

Journal article

The systems biology approach to drug development: application to toxicity assessment of cardiac drugs.

Abstract:
Side effects account for most of the instances of failure of candidate drugs at late stages of development. These development failures contribute to the exorbitant cost of bringing new compounds to market: a single withdrawal can represent a loss of more than $1 billion. Many unwanted actions of drugs affect the heart, resulting in potentially proarrhythmic alteration of ion channel function. Because these can be fatal, potential electrophysiological cardiotoxicity is among the most stringent exclusion criteria in the licensing process.
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1038/clpt.2010.95

Authors


Expand authors...
Journal:
Clinical pharmacology and therapeutics
Volume:
88
Issue:
1
Pages:
130-134
Publication date:
2010-07-05
DOI:
EISSN:
1532-6535
ISSN:
0009-9236
URN:
uuid:2328bcb2-3473-440f-b06e-7adbf4bfc786
Source identifiers:
64443
Local pid:
pubs:64443

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP